We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mediazest Plc | LSE:MDZ | London | Ordinary Share | GB00B064NT52 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.075 | 0.07 | 0.08 | 0.075 | 0.075 | 0.08 | 4,461,694 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 2.34M | -553k | -0.0003 | -2.33 | 1.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/11/2019 09:30 | Just curious. You went to the GM and voted for the resolution. Why bother going. | russman | |
17/11/2019 11:04 | About 450 million for and none against for the resolutions. Went along. LS | liberatingsteptoe | |
14/11/2019 09:10 | No excuses were made. It would be interesting what the vote count was. When do you think the placing will be. & for how much - another £100k? | russman | |
31/10/2019 11:10 | In 2009 the nominal value was decreased from 10p to 0.1p per share. Net assets would be half share capital. It would be interesting what excuses Lance makes for this "serious loss of capital". & where is this elusive jam. | russman | |
30/10/2019 08:50 | Special Resolution requires 75% of the vote. If it is not passed, the co cannot have a placing at the new lower nominal. It would give Lance motivation to get the share price above 0.1p | russman | |
28/10/2019 20:16 | Don't be fooled by any positive spin up to and just after the GM. A placing will be forthcoming at below 0.1p. | knicol46 | |
28/10/2019 19:36 | It gets worse! It has recently come to the attention of the Board that the value of the Company's net assets has become less than half of its called-up share capital. It is a requirement of section 656 of the Companies Act that, where the net assets of a public company are half or less of its called-up share capital, the directors must call a general meeting of the company to consider whether any, and if so what, steps should be taken to deal with the situation. This is termed a serious loss of capital. Accordingly, the business to be conducted at the General Meeting will also include consideration of what, if any, such steps should be taken. The Board is of the view that the serious loss of capital does not pose any risk to the solvency of the Company, therefore no specific measures are proposed to deal with the serious loss of capital. Notwithstanding, the Board recognises this technical requirement and invites Shareholders to discuss accordingly. | frjdnverijtnhj8568934 | |
28/10/2019 17:14 | What were In Ur Face Media thinking buying into this? | frjdnverijtnhj8568934 | |
28/10/2019 16:49 | "As a result of challenging market conditions, the existing ordinary shares of 0.1p each in the capital of the Company (the “Existing Ordinary Shares”) have, at times, traded on AIM at a price less than the nominal value of such shares. " LOL. It has nothing to do with "challenging market conditions". The reason for the share price is everyone knows this company is just going to announce placing after placing after placing, after placing. They've been doing it for 12 years since IPO. | frjdnverijtnhj8568934 | |
28/10/2019 16:41 | yes agree knicol. IMO the last trading update was supposed to put a rocket under the share price to hopefully get the shares above 0.1p but everyone has heard the same old rubbish for years now so it no longer works. | frjdnverijtnhj8568934 | |
28/10/2019 14:31 | Management have no confidence in the share price going above the nominal price of 0.1p anytime soon. They have decided to have the nominal share price reduced to 0.01p - shafting to follow. | knicol46 | |
27/10/2019 16:36 | Please see SKIN - about to move up. 1) Laboratory grown human skin that can be tested on, instead of testing on animals 2) Only commercially available option of its type. 3) Exploiting high growth technologies such as Artificial Intelligence 4) Human skin cloning duplicates test subjects 5) It is an Ethical investment 6) Exploiting CBD market 7) Cutting edge Woundcare -Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing. 8) Expanding laboratory space by 100% to accommodate the rate of growth due to be RNS any day 9) Currently negotiating further contracts. (8 CBD we know of and others) due to be RNS soon 10) Fully funded - The growth of the Company has been so well supported and received by the market that all corporate activity has been achieved, funding in place to accommodate the continued growth. 11) Meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company 12) Four Blue-Chip (US and EU) client agreements signed 13) owns 9.35% of Cellulac plc 14) Algzym - A patented enzyme-based technology which bursts algal cell walls and releases Omega 3 oils in a simple solvent-free process. 15) Company moving forward at a rapid pace. 16) Major relationships already built with billion-dollar companies 17) Sales routes for products already in place in multiple countries 18) EU laws changing to force companies to stop beauty and pharmaceuticals testing on animals. 19) EU laws changing to force companies to stop making claims they can't back up scientifically. 20) EU laws changing to force companies to comply with more rigorous testing before market launch. 21) Presenting at major US and European Skin and Dermatology events 22) Presenting at major CBD Exhibitions 23) Strong, dynamic and driven board 24) CEO is an owner of company/major investor The chart is primed for a great entry' | lisae123 | |
02/10/2019 06:02 | Lance pls repay EP&F our loan now. | russman | |
01/10/2019 07:14 | If you invested £1000 at IPO its now worth £1.20! The begging bowl will be getting prepared for its annual outing | frjdnverijtnhj8568934 | |
30/9/2019 19:13 | What has 4 legs, a long snout, tail and barks. Look around. The LSE and twitter pumper will be long gone once he has pumped this enough. Ridddddddiculous. | texaschaser | |
29/9/2019 17:09 | Can see it happening. Loans converted into .1p shares. | russman | |
27/9/2019 09:08 | jackanory it is. Same old rubbish. There must be a placing coming. | frjdnverijtnhj8568934 | |
27/9/2019 09:08 | jackanory it is. Same old rubbish. There must be a placing coming. | frjdnverijtnhj8568934 | |
27/9/2019 08:12 | Same old Jackanory. & where is the working capital going to come from? | russman | |
10/9/2019 09:06 | Annual Report out. No resolution for share consolidation. Read related party transactions. Cash is very low. Loan, more loans.. | russman | |
06/9/2019 07:58 | Annual not published yet. If AGM is Friday 27th - 21 clear days notice is required. There has to be a resolution to consolidate the shares or another cash call would be very difficult at the current share price. | russman | |
29/8/2019 07:38 | 6k net profit. Retained earnings decreased 112k. IFRS added 117k to gross profit =6-117=-112k (rounded) Say the contracts were more conservatively valued by more than 6k. It would be another loss. I await the Annual Report to look at cash movements. | russman | |
28/8/2019 13:01 | They claim to have made a profit of £6,000 even though the net asset value of the company has REDUCED over the year. How is this possible? It looks like a another loss in all but name. | frjdnverijtnhj8568934 | |
24/8/2019 07:58 | Def not this Monday. | russman | |
17/8/2019 10:17 | Shares now look to be at a new all time low. | ochs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions